The Automated Screening Working Groups is a group of software engineers and biologists passionate about improving scientific manuscripts on a large scale. Our members have created tools that check for common problems in scientific manuscripts, including information needed to improve transparency and reproducibility. We have combined our tools into a single pipeline, called ScreenIT. We're currently using our tools to screen COVID preprints.

About Followers

Latest preprint reviews

  1. Flocked swab might be one main reason causing the high false-negative rate in COVID-19 screening----the advantages of a novel silicone swab

    1. Jianye Zhou
    2. Zhongtian Bai
    3. Xiaoping Liu
    4. Yaqiong Guo
    5. Nan Jiang
    6. Xiaodong Li
    7. Xiaohui Zhang
    8. Zhiqiang Li
    9. Yonghong Li
    10. Zhongren Ma
    11. Jin Zhao

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  2. Disruption of Adaptive Immunity Enhances Disease in SARS-CoV-2-Infected Syrian Hamsters

    1. Rebecca L. Brocato
    2. Lucia M. Principe
    3. Robert K. Kim
    4. Xiankun Zeng
    5. Janice A. Williams
    6. Yanan Liu
    7. Rong Li
    8. Jeffrey M. Smith
    9. Joseph W. Golden
    10. Dave Gangemi
    11. Sawsan Youssef
    12. Zhongde Wang
    13. Jacob Glanville
    14. Jay W. Hooper

    Reviewed by ScreenIT

    2 evaluationsAppears in 1 listLatest version Latest activity

  3. Opposing roles for sMAdCAM and IL-15 in COVID-19 associated cellular immune pathology

    1. Amit Kumar Singh
    2. Nandini Kasarpalkar
    3. Shilpa Bhowmick
    4. Gaurav Paradkar
    5. Mayur Talreja
    6. Karan Shah
    7. Abhishek Tiwari
    8. Harsha Palav
    9. Snehal Kaginkar
    10. Rajiv Kulkarni
    11. Ashwini Patil
    12. Varsha Kalsurkar
    13. Sachee Agrawal
    14. Jayanthi Shastri
    15. Rajesh Dere
    16. Ramesh Bharmal
    17. Smita D Mahale
    18. Vikrant M Bhor
    19. Vainav Patel

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  4. Neutralizing activity of Sputnik V vaccine sera against SARS-CoV-2 variants

    1. Satoshi Ikegame
    2. Mohammed N. A. Siddiquey
    3. Chuan-Tien Hung
    4. Griffin Haas
    5. Luca Brambilla
    6. Kasopefoluwa Y. Oguntuyo
    7. Shreyas Kowdle
    8. Hsin-Ping Chiu
    9. Christian S. Stevens
    10. Ariel Esteban Vilardo
    11. Alexis Edelstein
    12. Claudia Perandones
    13. Jeremy P. Kamil
    14. Benhur Lee

    Reviewed by Rapid Reviews Infectious Diseases, ScreenIT

    4 evaluationsAppears in 2 listsLatest version Latest activity

  5. High-resolution profiling of MHC II peptide presentation capacity reveals SARS-CoV-2 CD4 T cell targets and mechanisms of immune escape

    1. Franz-Josef Obermair
    2. Florian Renoux
    3. Sebastian Heer
    4. Chloe H. Lee
    5. Nastassja Cereghetti
    6. Marisa Loi
    7. Giulia Maestri
    8. Yannick Haldner
    9. Robin Wuigk
    10. Ohad Iosefson
    11. Pooja Patel
    12. Katherine Triebel
    13. Manfred Kopf
    14. Joanna Swain
    15. Jan Kisielow

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  6. Optimization of an LNP-mRNA vaccine candidate targeting SARS-CoV-2 receptor-binding domain

    1. Kouji Kobiyama
    2. Masaki Imai
    3. Nao Jounai
    4. Misako Nakayama
    5. Kou Hioki
    6. Kiyoko Iwatsuki-Horimoto
    7. Seiya Yamayoshi
    8. Jun Tsuchida
    9. Takako Niwa
    10. Takashi Suzuki
    11. Mutsumi Ito
    12. Shinya Yamada
    13. Tokiko Watanabe
    14. Maki Kiso
    15. Hideo Negishi
    16. Burcu Temizoz
    17. Hirohito Ishigaki
    18. Yoshinori Kitagawa
    19. Cong Thanh Nguyen
    20. Yasushi Itoh
    21. Fumihiko Takeshita
    22. Yoshihiro Kawaoka
    23. Ken J. Ishii

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  7. In vivo evaluation of the virucidal efficacy of chlorhexidine and povidone-iodine mouthwashes against salivary SARS-CoV-2. A randomized-controlled clinical trial

    1. Rola Elzein
    2. Fadi Abdel-Sater
    3. Soha Fakhreddine
    4. Pierre Abi Hanna
    5. Rita Feghali
    6. Hassan Hamad
    7. Fouad Ayoub

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  8. Maximization of Open Hospital Capacity under Shortage of SARS-CoV-2 Vaccines—An Open Access, Stochastic Simulation Tool

    1. Wolfram A. Bosbach
    2. Martin Heinrich
    3. Rainer Kolisch
    4. Christian Heiss

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  9. Convalescent-Phase Sera and Vaccine-Elicited Antibodies Largely Maintain Neutralizing Titer against Global SARS-CoV-2 Variant Spikes

    1. Takuya Tada
    2. Belinda M. Dcosta
    3. Marie I. Samanovic
    4. Ramin S. Herati
    5. Amber Cornelius
    6. Hao Zhou
    7. Ada Vaill
    8. Wes Kazmierski
    9. Mark J. Mulligan
    10. Nathaniel R. Landau

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  10. Neutralization of B.1.1.28 P2 variant with sera of natural SARS-CoV-2 infection and recipients of BBV152 vaccine

    1. Gajanan Sapkal
    2. Pragya D. Yadav
    3. Raches Ella
    4. Priya Abraham
    5. Deepak Y. Patil
    6. Nivedita Gupta
    7. Samiran Panda
    8. V. Krishna Mohan
    9. Balram Bhargava

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity
Newer Page 2172 of 2361 Older